15–34 | 35–59 | ≥60 | Total | p-value | |
---|---|---|---|---|---|
Non-multidrug-resistance TB | 692 (100.0%) | 1512 (100.0%) | 2034 (100.0%) | 4238 (100.0%) | |
Resistance to any FQa | 5 (0.7%) | 15 (1.0%) | 19 (0.9%) | 39 (0.9%) | 0.824 |
Ofx resistance | 4 (0.6%) | 15 (1.0%) | 18 (0.9%) | 37 (0.9%) | 0.623 |
Lfx resistance | 5 (0.7%) | 15 (1.0%) | 19 (0.9%) | 39 (0.9%) | 0.824 |
Mfx resistance | 4 (0.6%) | 12 (0.8%) | 17 (0.8%) | 33 (0.8%) | 0.798 |
Multidrug-resistance TB | 42 (100.0%) | 81 (100.0%) | 56 (100.0%) | 179 (100.0%) | |
Resistance to any FQa | 11 (26.2%) | 14 (17.3%) | 11 (19.6%) | 36 (20.1%) | 0.502 |
Ofx resistance | 11 (26.2%) | 12 (14.8%) | 11 (19.6%) | 34 (19.0%) | 0.309 |
Lfx resistance | 10 (23.8%) | 13 (16.0%) | 11 (19.6%) | 34 (19.0%) | 0.576 |
Mfx resistance | 10 (23.8%) | 10 (12.3%) | 11 (19.6%) | 31 (17.3%) | 0.241 |